Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines

Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines

Bibliographic Details
Main Authors:	Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Arturo Casadevall, Michael J. Joyner
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	Journal of Clinical Virology Plus
Subjects:	COVID19 SARS-CoV-2 Monoclonal antibodies Convalescent plasma Immunosuppression
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667038022000679

Similar Items

Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
by: Massimo Franchini, et al.
Published: (2024-02-01)

Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe
by: Daniele Focosi, et al.
Published: (2022-10-01)

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
by: Daniele Focosi, et al.
Published: (2021-08-01)

The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review
by: Massimo Franchini, et al.
Published: (2023-12-01)

Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
by: Massimo Franchini, et al.
Published: (2021-09-01)

A Descriptive, Retrospective Analysis of COVID-19 Passive Antibody Therapy and Its Effects on Morbidity and Mortality in Patients Receiving B-Cell-Depleting Therapies
by: Sonia Gentile, et al.
Published: (2024-02-01)

Clinical and Virological Response to Convalescent Plasma in a Chronic Lymphocytic Leukemia Patient with COVID-19 Pneumonia
by: Giovanni Belcari, et al.
Published: (2022-07-01)

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
by: Massimo Franchini, et al.
Published: (2023-01-01)

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial
by: Rada M. Grubovic Rastvorceva, et al.
Published: (2022-10-01)

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
by: David Sullivan, et al.
Published: (2023-06-01)

Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
by: Daniele Focosi, et al.
Published: (2021-12-01)

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy
by: Daniele Focosi, et al.
Published: (2022-10-01)

Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
by: Massimo Franchini, et al.
Published: (2024-02-01)

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
by: David J. Sullivan, et al.
Published: (2022-10-01)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
by: Latha Dulipsingh, et al.
Published: (2023-06-01)

Korean version of the convalescence and recovery evaluation: translation and linguistic validation
by: Hyeong Dong Yuk, et al.
Published: (2020-12-01)

The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01)

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
by: Laura Thümmler, et al.
Published: (2022-12-01)

Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
by: Massimo Franchini, et al.
Published: (2021-06-01)

Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
by: Massimo Franchini, et al.
Published: (2022-06-01)

Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience
by: Massimo Franchini, et al.
Published: (2022-03-01)

Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
by: Daniele Focosi, et al.
Published: (2023-08-01)

The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
by: Effat Iranijam, et al.
Published: (2022-01-01)

Biomarkers of sequela in adult patients convalescing from COVID-19
by: Vianed Marsán-Suárez, et al.
Published: (2022-01-01)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
by: Daniele Focosi, et al.
Published: (2021-06-01)

Convalescent plasma therapy in COVID-19
by: Ayse Uysal, et al.
Published: (2022-06-01)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
by: Daniele Focosi, et al.
Published: (2021-02-01)

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
by: Tengfei Ma, et al.
Published: (2022-01-01)

Use of convalescent plasma to treat COVID-19: case studies
by: Stéphani Caroline Beneti, et al.
Published: (2023-07-01)

Identifying the Effective Factors in the Death of Patients Receiving Convalescent Plasma
by: Leili Yekefallah, et al.
Published: (2022-03-01)

Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
by: Anna Moniuszko-Malinowska, et al.
Published: (2020-12-01)

Development and validation of the Convalescence Symptom Assessment Scale for EsophageCtomy patients
by: Hui Ge, et al.
Published: (2024-02-01)

Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
by: Nicholas E. Larkey, et al.
Published: (2022-08-01)

Rapid Clinical and Radiological Improvement in a Patient with Severe COVID-19 Infection Treated with Convalescent Plasma
by: Stephen Malnick, et al.
Published: (2021-05-01)

Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses
by: Yuan Peng, et al.
Published: (2022-12-01)

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19
by: Monika Maria Biernat, et al.
Published: (2021-03-01)

Potential predictors of outcomes among hospitalized COVID-19 patients treated with convalescent plasma: a single-center study
by: Sridhar Chilimuri, et al.
Published: (2021-07-01)

Acute Malaria in Malawian Children and Adults is Characterized by Thrombocytopenia That Normalizes in Convalescence
by: Mandala W, et al.
Published: (2022-09-01)

Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study
by: Ahmet Omma, et al.
Published: (2021-12-01)

Prediction of early falls using adherence and balance assessments in a convalescent rehabilitation ward
by: Toshio Teranishi, et al.
Published: (2024-02-01)